Apeloa Pharmaceutical Co.,Ltd
000739
Hisse Senetlerindeki Sıralama
#4306
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Hisse Fiyatı
$3.17
Piyasa Değeri
$3.67B
Değişim (1 gün)
0.76%
Değişim (1 yıl)
40.57%
Ülke
CN
Ticaret Apeloa Pharmaceutical Co.,Ltd (000739)
Kategori
Healthcare
Apeloa Pharmaceutical Co.,Ltd (000739) için temettü verimi geçmişi
Apeloa Pharmaceutical Co.,Ltd (hisse sembolü: 000739) temettü verimi (TTM) 2023-12-31 itibariyle: 2.11%
Son 5 yılın ortalama temettü verimi: 1.39%
Son 5 yılın ortalama temettü verimi: 1.39%
Apeloa Pharmaceutical Co.,Ltd (000739) için 2000 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
| Yıl | Temettü Verimi | Değiştir |
|---|---|---|
| 2026 (TTM) | 1.58% | -25.82% |
| 2024 | 2.13% | 0.95% |
| 2023 | 2.11% | 58.65% |
| 2022 | 1.33% | 92.75% |
| 2021 | 0.69% | -2.82% |
| 2020 | 0.71% | -16.47% |
| 2019 | 0.85% | -37.96% |
| 2018 | 1.37% | -27.51% |
| 2017 | 1.89% | 26.00% |
| 2016 | 1.50% | -13.29% |
| 2015 | 1.73% | 61.68% |
| 2014 | 1.07% | -43.68% |
| 2013 | 1.90% | -63.60% |
| 2012 | 5.22% | 338.66% |
| 2011 | 1.19% | -10.53% |
| 2010 | 1.33% | -8.90% |
| 2009 | 1.46% | -60.96% |
| 2008 | 3.74% | 128.05% |
| 2007 | 1.64% | -45.15% |
| 2006 | 2.99% | -43.58% |
| 2005 | 5.30% | 46.81% |
| 2004 | 3.61% | 37.79% |
| 2003 | 2.62% | 12.93% |
| 2002 | 2.32% | 286.67% |
| 2001 | 0.60% | 81.82% |
| 2000 | 0.33% | 0.00% |
Benzer şirketler veya rakiplerin temettü verimi (TTM)
| Şirket | Temettü Verimi | Ülke |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
